{
    "title": "Gilead cuts 2020 sales outlook as COVID-19 drug remdesivir falls short",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8890609/COVID-19-drug-boosts-Gilead-quarterly-revenue-2020-sales-outlook-cut.html",
    "date": "2020-10-28",
    "keywords": [
        "remdesivir",
        "gilead",
        "covid19",
        "quarter",
        "demand",
        "company",
        "use",
        "revenue",
        "officer",
        "surge",
        "street",
        "world",
        "drug",
        "trial",
        "beasley",
        "difficulty",
        "treatment",
        "johanna",
        "mercier",
        "summer",
        "hospitalization",
        "assumption",
        "light",
        "fall",
        "europe",
        "end",
        "outlook",
        "revision",
        "guidance",
        "veklury",
        "dickinson",
        "brand",
        "name",
        "president",
        "bout",
        "inventory",
        "volume",
        "government",
        "stockpiling",
        "standard",
        "care",
        "illness",
        "uncertainty",
        "pandemic",
        "visibility",
        "analyst",
        "michael",
        "antibody",
        "trading",
        "thirdquarter",
        "estimate",
        "share",
        "companys",
        "flagship",
        "hiv",
        "year",
        "disruption",
        "emergency",
        "authorization",
        "food",
        "administration",
        "july",
        "month",
        "health",
        "patient",
        "chander",
        "bengaluru",
        "editing",
        "dasgupta",
        "bill",
        "berkrot"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}